Viewing Study NCT00588094


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-28 @ 12:05 AM
Study NCT ID: NCT00588094
Status: COMPLETED
Last Update Posted: 2015-12-04
First Post: 2007-12-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHL
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: